Directory Hormones and their antagonists Estrogens, gestagena; Their homologues and antagonists Diana-35
This page is translated automatically with a help of Google Translate

Diana-35

See also Exemestane

Roman name

Diane - 35

Indications

Androgenzawisimae giperandrogenne disease in women : skin (especially forms accompanied by seboreei, vospaleniami and education units), alopecia, girsutizm, contraception for women, including suffering from these diseases.

Pregnancy and lactation

Contraindicated in pregnancy. At the time of treatment should stop breastfeeding.

Contraindications

Pregnancy, breast feeding, liver failure, jaundice idiopathic or severe skin itching in pregnancy anemneze (formerly), Dubin-jonson syndromes (hereditary liver disease accompanied by jaundice), and fell (hereditary liver disease characterized by moderate increases in the blood of cium), cancer breast or endometrium (internal layer cancer), even after treatment, Violations Fat exchange puzarchaty dermatos (skin disease), with the pregnancy in history, otoscleros (progressive hearing impairment and noise in the ears), with the deterioration in the course of pregnancy.

Side-Effects

The sense of pressure in the chest, stomach, nausea, headaches, changes in body weight and sexual desire, depressive state (of frustration), hloazma (jeltovato-coricneve blotches on the skin), intermediate haemorrhage. Strong headaches (migraines), severe visual impairment, the first symptoms trombophlebitis (inflammation of the walls of veins with their zakuporka) or tromboambolicekih phenomena (of vehicles receptacles), the appearance of jaundice, a strong increase in blood pressure.

Dosing and Administration

In order to prevent pregnancy in the first cycle of treatment are taken on one tablet from the 5th-25th day menstrual cycle, as the first day of menstruation first day cycle. The day after the break, during which there bleeding, beginning next package (21 tablets) product.

Storage conditions

List B. In the dark spot.

Shelf life

5 years

The registration

012240/01-2000

Of drugs

Antiandrogenny (oppressive education and / or decreasing the male sex hormones) gel product. Oral (used in the mouth) contraceptives.

Indications for use

Preventing pregnancy in women with the phenomena androgenization (the emergence of women's features caused by the male sex hormone). El androgenization (acne / acne / palliative, milder androgeneticescoy allopetion / treated women by the action of the male sex hormones / girsutizm / excess owolosenie women in a male /).

Form of

Tablets containing 2 mg ciproteron acetate and 0.035 mg etinilestradiola, in a package stuke 21; 3 * 21 pcs. and 6h21 pcs.

All products of this group